MAPT and Alzheimer disease: Furthermore, plasma p-tau181 can identify AD pathophysiology with high accuracy (Lantero Rodriguez et al., 2020), because it distinguishes AD and non-AD neurodegeneration is similar to tau-PET and CSF p-tau181 (Janelidze et al., 2020).